Korean J Hepatol.  2004 Dec;10(4):279-287.

Positron Emission Tomography with Fluorine-18-Fluorodeoxyglucose is Useful for Predicting the Prognosis of Patients with Hepatocellular Carcinoma

Affiliations
  • 1Department of Internal Medicine, Korea Institute of Radiological and Medical Sciences, Seoul, Korea. chulju@kcch.re.kr
  • 2Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.

Abstract

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is heterogenous in terms of its glucose metabolism. Positron emission tomography with fluorine-18-fluorodeoxyglucose (FDG-PET) shows various levels of FDG uptake for patients with HCC. This study was designed to assess the usefulness of FDG-PET for predicting the outcome of the patients with HCC. METHODS: FDG-PET was performed for 27 patients with HCC. The standardized uptake value (SUV) and SUV ratio (defined as the tumor-to-nontumor ratio of SUV) was calculated for each patient. The clinical factors of the outcome were analyzed by regression analysis using Cox's multivariate proportional hazard model. The survival rate was calculated by the Kaplan-Meier method. RESULTS: Among the analyzed clinical factors including tumor size, number of tumors, AFP, involvement of major vessels, presence of systemic metastases, Child-Pugh class the SUV and SUV ratio, only the SUV was the only significant independent prognostic factor (p=0.001). On the basis of the SUV, the patients were divided into two groups of roughly equal size: group A, SUV of <7; group B, SUV >or=7. The cumulative survival rate was significantly lower for group B than for group A, and the median survival time was significantly different (4 months vs 15 months, respectively) (p=0.003). CONCLUSIONS: These results suggest that FDG-PET is useful to predict the outcome for patients with hepatocellular carcinoma.

Keyword

Hepatocellular carcinoma; Positron emission tomography; Prognosis

MeSH Terms

Adult
Aged
Carcinoma, Hepatocellular/mortality/*radionuclide imaging
English Abstract
Female
Fluorodeoxyglucose F18/*diagnostic use
Humans
Liver Neoplasms/mortality/*radionuclide imaging
Male
Middle Aged
*Positron-Emission Tomography
Prognosis
Radiopharmaceuticals/*diagnostic use
Survival Rate
Full Text Links
  • KJHEP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr